Breaking News Instant updates and real-time market news.

BTAI

BioXcel Therapeutics

$23.68 /

+4.79 (+25.36%)

09:27
02/14/20
02/14
09:27
02/14/20
09:27

BioXcel soars after SunTrust more than sextuples price target to $150

Shares of BioXcel Therapeutics are soaring after SunTrust Robinson Humphrey analyst Robyn Karnauskas more than sextupled her price target on the shares to $150 from $24. The stock in premarket trading is up 74%, or $17.60, to $41.45. The rarely seen target quintuple came after the analyst did greater due diligence and added sales for opioid withdrawal, adjusted the company's dementia/schizophrenia/bipolar sales to more accurately reflect the market opportunity, and adjusted its operating expenses to more accurately reflect sales synergies and lower R&D costs. With two pivotal trials and two Phase 2 trials this year, "investors are missing how quickly these datasets will come and also how quickly the company can complete additional Phase 3 trials," Karnauskas tells investors in a research note. She believes the opioid withdrawal market represents a meaningful opportunity with 18% of 2M patients seeking treatment. The analyst models $1B in unadjusted peak sales with a 50% probability for BXCL501. Further, Karnauskas believes BioXcel's pivotal Phase 3 trials in schizophrenia/bipolar will be successful and launch in the second half of 2021. She models $1.5B in peak sales for dementia with 30% market penetration. In addition, every additional 10% market penetration in schizophrenia/bipolar would add $17 to her discounted cash flow model and every additional 10% market penetration in dementia would add $24

  • 24

    Mar

BTAI BioXcel Therapeutics
$23.68 /

+4.79 (+25.36%)

02/14/20 Truist
BioXcel Therapeutics price target raised to $150 from $24 at SunTrust
01/16/20 BMO Capital
BioXcel Therapeutics price target raised to $26 from $21 at BMO Capital
01/08/20 H.C. Wainwright
BioXcel Therapeutics price target raised to $30 from $25 at H.C. Wainwright
12/31/19 Canaccord
BioXcel Therapeutics price target raised to $27 from $24 at Canaccord

TODAY'S FREE FLY STORIES

Periodicals
Judge orders Lyft, Uber to convert CA to employees with benefits, Bloomberg says » 17:02
08/10/20
08/10
17:02
08/10/20
17:02
UBER

Uber

$32.10 /

-0.8 (-2.43%)

, LYFT

Lyft

$31.03 /

+0.84 (+2.78%)

Uber (UBER) and Lyft…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
UBER Uber
$32.10 /

-0.8 (-2.43%)

LYFT Lyft
$31.03 /

+0.84 (+2.78%)

UBER Uber
$32.10 /

-0.8 (-2.43%)

08:21 Today Guggenheim
Uber price target raised to $40 from $37 at Guggenheim
08/07/20 RBC Capital
Uber price target raised to $50 from $45 at RBC Capital
08/07/20 Stifel
Uber price target raised to $40 from $38 at Stifel
08/07/20 Morgan Stanley
Uber price target raised to $46 from $44 at Morgan Stanley
LYFT Lyft
$31.03 /

+0.84 (+2.78%)

07:51 Today Jefferies
Lyft price target lowered to $40 from $50 at Jefferies
07:41 Today Credit Suisse
Lyft price target lowered to $66 from $75 at Credit Suisse
08/05/20 Deutsche Bank
Lyft price target lowered to $57 from $60 at Deutsche Bank
07/22/20 Raymond James
Lyft resumed with a Market Perform at Raymond James
UBER Uber
$32.10 /

-0.8 (-2.43%)

LYFT Lyft
$31.03 /

+0.84 (+2.78%)

  • 11
    Feb
  • 07
    Nov
  • 06
    Nov
UBER Uber
$32.10 /

-0.8 (-2.43%)

LYFT Lyft
$31.03 /

+0.84 (+2.78%)

UBER Uber
$32.10 /

-0.8 (-2.43%)

LYFT Lyft
$31.03 /

+0.84 (+2.78%)

UBER Uber
$32.10 /

-0.8 (-2.43%)

LYFT Lyft
$31.03 /

+0.84 (+2.78%)

Earnings
Addus HomeCare reports Q2 adjusted EPS 73c, consensus 49c » 17:02
08/10/20
08/10
17:02
08/10/20
17:02
ADUS

Addus HomeCare

$101.50 /

+2.05 (+2.06%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ADUS Addus HomeCare
$101.50 /

+2.05 (+2.06%)

ADUS Addus HomeCare
$101.50 /

+2.05 (+2.06%)

06/17/20 Baird
Addus HomeCare price target raised to $100 from $96 at Baird
03/20/20 RBC Capital
RBC says Addus HomeCare selloff unwarranted as lockdowns don't apply
12/10/19 Oppenheimer
Addus HomeCare price target raised to $107 from $96 at Oppenheimer
11/21/19 RBC Capital
Addus HomeCare price target raised to $109 from $100 at RBC Capital
ADUS Addus HomeCare
$101.50 /

+2.05 (+2.06%)

  • 05
    Sep
Hot Stocks
Ritchie Bros. names Kevin Geisner as Chief Strategy Officer » 17:02
08/10/20
08/10
17:02
08/10/20
17:02
RBA

Ritchie Bros.

$58.16 /

+2.48 (+4.45%)

Ritchie Bros. announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RBA Ritchie Bros.
$58.16 /

+2.48 (+4.45%)

RBA Ritchie Bros.
$58.16 /

+2.48 (+4.45%)

08/07/20 Barrington
Ritchie Bros. downgraded to Market Perform on valuation at Barrington
08/07/20 Barrington
Ritchie Bros. downgraded to Market Perform from Outperform at Barrington
06/10/20 National Bank
Ritchie Bros. downgraded to Underperform from Sector Perform at National Bank
05/11/20 Raymond James
Ritchie Bros. downgraded to Market Perform from Outperform at Raymond James
RBA Ritchie Bros.
$58.16 /

+2.48 (+4.45%)

Earnings
National Health Investors reports Q2 AFFO $1.35, consensus $1.43 » 17:01
08/10/20
08/10
17:01
08/10/20
17:01
NHI

National Health Investors

$66.26 /

+0.66 (+1.01%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NHI National Health Investors
$66.26 /

+0.66 (+1.01%)

NHI National Health Investors
$66.26 /

+0.66 (+1.01%)

06/17/20 Wells Fargo
National Health Investors price target raised to $66 from $54 at Wells Fargo
06/08/20 JMP Securities
National Health Investors resumed with a Market Perform at JMP Securities
05/22/20 Mizuho
National Health Investors downgraded to Neutral from Buy at Mizuho
04/23/20 SunTrust
SunTrust lowers price targets on select healthcare REITS
NHI National Health Investors
$66.26 /

+0.66 (+1.01%)

Downgrade
Varian downgraded to Neutral from Buy at BTIG » 17:01
08/10/20
08/10
17:01
08/10/20
17:01
VAR

Varian

$173.46 /

-0.1 (-0.06%)

, SMMNY

Siemens Healthineers

$0.00 /

+ (+0.00%)

BTIG analyst Marie…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VAR Varian
$173.46 /

-0.1 (-0.06%)

SMMNY Siemens Healthineers
$0.00 /

+ (+0.00%)

VAR Varian
$173.46 /

-0.1 (-0.06%)

08/06/20 UBS
Varian downgraded to Neutral from Buy at UBS
08/03/20 Deutsche Bank
Siemens Healthineers Hold rating reaffirmed at Deutsche Bank
08/03/20 Citi
Siemens Healthineers had 'clear' rational to acquire Varian, says Citi
08/03/20 Jefferies
Jefferies sees room for potentially higher bid for Varian
SMMNY Siemens Healthineers
$0.00 /

+ (+0.00%)

08/07/20 Kepler Cheuvreux
Siemens Healthineers upgraded to Buy from Hold at Kepler Cheuvreux
08/06/20 UBS
Varian downgraded to Neutral from Buy at UBS
08/04/20 AlphaValue
Siemens Healthineers downgraded to Sell from Reduce at AlphaValue
08/04/20 DZ Bank
Siemens Healthineers downgraded to Hold from Buy at DZ Bank
VAR Varian
$173.46 /

-0.1 (-0.06%)

VAR Varian
$173.46 /

-0.1 (-0.06%)

SMMNY Siemens Healthineers
$0.00 /

+ (+0.00%)

VAR Varian
$173.46 /

-0.1 (-0.06%)

Earnings
Acacia Communications reports Q2 EPS 65c, consensus 50c » 17:00
08/10/20
08/10
17:00
08/10/20
17:00
ACIA

Acacia Communications

$68.29 /

+ (+0.00%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ACIA Acacia Communications
$68.29 /

+ (+0.00%)

ACIA Acacia Communications
$68.29 /

+ (+0.00%)

09/23/19 Northland
Inphi drops after Northland sees 'large cut' to Amazon 400G rollout plans
ACIA Acacia Communications
$68.29 /

+ (+0.00%)

ACIA Acacia Communications
$68.29 /

+ (+0.00%)

ACIA Acacia Communications
$68.29 /

+ (+0.00%)

Earnings
Fortress Biotech reports Q2 non-GAAP EPS (5c), consensus (27c) » 17:00
08/10/20
08/10
17:00
08/10/20
17:00
FBIO

Fortress Biotech

$3.31 /

+0.27 (+8.88%)

Reports Q2 revenue $9.5M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FBIO Fortress Biotech
$3.31 /

+0.27 (+8.88%)

FBIO Fortress Biotech
$3.31 /

+0.27 (+8.88%)

04/13/20 B. Riley FBR
AstraZeneca study halt has positive read-through to Fortress, says B. Riley FBR
02/13/20
Fly Intel: Top five analyst initiations
02/12/20 Cantor Fitzgerald
Fortress Biotech initiated with an Overweight at Cantor Fitzgerald
12/18/19 B. Riley FBR
Fortress Biotech initiated with a Buy at B. Riley FBR
FBIO Fortress Biotech
$3.31 /

+0.27 (+8.88%)

Syndicate
OneConnect announces offering of 16.5M American Depositary shares » 16:58
08/10/20
08/10
16:58
08/10/20
16:58
OCFT

OneConnect

$20.22 /

-0.6 (-2.88%)

OneConnect Financial…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
OCFT OneConnect
$20.22 /

-0.6 (-2.88%)

OCFT OneConnect
$20.22 /

-0.6 (-2.88%)

07/21/20 JPMorgan
OneConnect downgraded to Neutral from Overweight at JPMorgan
06/23/20 KeyBanc
OneConnect price target raised to $22 from $14 at KeyBanc
02/21/20 Goldman Sachs
OneConnect downgraded to Neutral from Buy at Goldman Sachs
01/23/20 JPMorgan
OneConnect initiated with an Overweight at JPMorgan (yesterday)
OCFT OneConnect
$20.22 /

-0.6 (-2.88%)

  • 13
    Dec
Earnings
NCS Multistage reports Q2 EPS (19c), consensus (27c) » 16:57
08/10/20
08/10
16:57
08/10/20
16:57
NCSM

NCS Multistage

$0.68 /

-0.018 (-2.58%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NCSM NCS Multistage
$0.68 /

-0.018 (-2.58%)

NCSM NCS Multistage
$0.68 /

-0.018 (-2.58%)

03/13/20 Wells Fargo
Drillers downgraded at Wells Fargo on recent sell off in commodity prices
03/13/20 Wells Fargo
NCS Multistage downgraded to Underweight from Equal Weight at Wells Fargo
NCSM NCS Multistage
$0.68 /

-0.018 (-2.58%)

NCSM NCS Multistage
$0.68 /

-0.018 (-2.58%)

Earnings
Mustang Bio reports Q2 EPS (32c), consensus (27c) » 16:56
08/10/20
08/10
16:56
08/10/20
16:56
MBIO

Mustang Bio

$3.46 /

+0.08 (+2.37%)

As of June 30, the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MBIO Mustang Bio
$3.46 /

+0.08 (+2.37%)

MBIO Mustang Bio
$3.46 /

+0.08 (+2.37%)

02/18/20 H.C. Wainwright
'Not a bad start' for Mustang Bio's MB-106 news, says H.C. Wainwright
01/09/20 Cantor Fitzgerald
Mustang Bio named top pick for 2020 at Cantor Fitzgerald
11/20/19 Cantor Fitzgerald
Mustang Bio assumed with an Overweight at Cantor Fitzgerald
08/13/19 H.C. Wainwright
Mustang Bio initiated with a Buy at H.C. Wainwright
  • 11
    Jun
MBIO Mustang Bio
$3.46 /

+0.08 (+2.37%)

Earnings
BRT Apartments reports Q2 FFO 24c, consensus 21c » 16:55
08/10/20
08/10
16:55
08/10/20
16:55
BRT

BRT Apartments

$10.99 /

+0.05 (+0.46%)

Reports Q2 revenue $6.8M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BRT BRT Apartments
$10.99 /

+0.05 (+0.46%)

BRT BRT Apartments
$10.99 /

+0.05 (+0.46%)

03/27/20 B. Riley FBR
BRT Apartments downgraded to Neutral from Buy at B. Riley FBR
BRT BRT Apartments
$10.99 /

+0.05 (+0.46%)

Earnings
Catalyst Pharmaceuticals reports Q2 EPS 9c, consensus 8c » 16:54
08/10/20
08/10
16:54
08/10/20
16:54
CPRX

Catalyst Pharmaceuticals

$4.26 /

+0.21 (+5.19%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CPRX Catalyst Pharmaceuticals
$4.26 /

+0.21 (+5.19%)

CPRX Catalyst Pharmaceuticals
$4.26 /

+0.21 (+5.19%)

11/13/19 Piper Jaffray
Catalyst Pharmaceuticals price target lowered to $7 from $8 at Piper Jaffray
10/09/19 Piper Jaffray
Catalyst should see limited impact from Ruzurgi launch, says Piper Jaffray
CPRX Catalyst Pharmaceuticals
$4.26 /

+0.21 (+5.19%)

  • 13
    Sep
CPRX Catalyst Pharmaceuticals
$4.26 /

+0.21 (+5.19%)

Hot Stocks
j2 Global up 14% after Q2 earnings beat at $68.50 per share  16:53
08/10/20
08/10
16:53
08/10/20
16:53
JCOM

j2 Global

$60.11 /

-1.32 (-2.15%)

 
ShowHide Related Items >><<
JCOM j2 Global
$60.11 /

-1.32 (-2.15%)

JCOM j2 Global
$60.11 /

-1.32 (-2.15%)

07/30/20 Susquehanna
j2 Global can double from current levels, says Susquehanna
07/16/20 Piper Sandler
j2 Global shares offer 'compelling' risk/reward, says Piper Sandler
07/02/20 Baird
j2 Global short report selloff a buying opportunity, says Baird
07/01/20 William Blair
j2 Global response addresses short report concerns, says William Blair
JCOM j2 Global
$60.11 /

-1.32 (-2.15%)

JCOM j2 Global
$60.11 /

-1.32 (-2.15%)

Earnings
Genasys reports Q3 EPS 4c, consensus 3c » 16:52
08/10/20
08/10
16:52
08/10/20
16:52
GNSS

Genasys

$4.18 /

+0.205 (+5.16%)

Reports Q3 revenue $12M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GNSS Genasys
$4.18 /

+0.205 (+5.16%)

Hot Stocks
Graphic Packaging acquiring $250M of ownership interest in partnership » 16:50
08/10/20
08/10
16:50
08/10/20
16:50
GPK

Graphic Packaging

$14.71 /

-0.04 (-0.27%)

Graphic Packaging has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GPK Graphic Packaging
$14.71 /

-0.04 (-0.27%)

GPK Graphic Packaging
$14.71 /

-0.04 (-0.27%)

07/13/20 Jefferies
Graphic Packaging assumed with a Hold at Jefferies
07/13/20 Jefferies
Graphic Packaging downgraded to Hold from Buy at Jefferies
06/15/20 Morgan Stanley
Graphic Packaging initiated with an Overweight at Morgan Stanley
04/07/20 Goldman Sachs
Goldman cuts paper and packaging estimates, prefers Ball and Graphic Packaging
GPK Graphic Packaging
$14.71 /

-0.04 (-0.27%)

Earnings
ChemoCentryx reports Q2 EPS 29c, consensus (34c) » 16:50
08/10/20
08/10
16:50
08/10/20
16:50
CCXI

ChemoCentryx

$55.86 /

+0.58 (+1.05%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CCXI ChemoCentryx
$55.86 /

+0.58 (+1.05%)

CCXI ChemoCentryx
$55.86 /

+0.58 (+1.05%)

07/09/20 Piper Sandler
ChemoCentryx submits NDA for avacopan in AAV to FDA, says Piper Sandler
06/16/20 BTIG
ChemoCentryx initiated with a Buy at BTIG
06/03/20 Piper Sandler
ChemoCentryx data highlights potential to challenge standards, Piper says
05/27/20 Wells Fargo
ChemoCentryx initiated with an Overweight at Wells Fargo
CCXI ChemoCentryx
$55.86 /

+0.58 (+1.05%)

  • 11
    Jun
CCXI ChemoCentryx
$55.86 /

+0.58 (+1.05%)

Hot Stocks
Bed Bath & Beyond says July comps were positive » 16:49
08/10/20
08/10
16:49
08/10/20
16:49
BBBY

Bed Bath & Beyond

$12.67 /

+0.55 (+4.54%)

In a regulatory 8-K…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BBBY Bed Bath & Beyond
$12.67 /

+0.55 (+4.54%)

BBBY Bed Bath & Beyond
$12.67 /

+0.55 (+4.54%)

07/10/20 Loop Capital
Bed Bath & Beyond price target raised to $9 from $5 at Loop Capital
07/07/20 Raymond James
Bed Bath & Beyond price target raised to $13 from $9 at Raymond James
05/26/20 Odeon Capital
Bed Bath & Beyond upgraded to Buy from Hold at Odeon Capital
04/16/20 Loop Capital
Bed Bath & Beyond Q4 results 'less bad than feared' says Loop Capital
BBBY Bed Bath & Beyond
$12.67 /

+0.55 (+4.54%)

BBBY Bed Bath & Beyond
$12.67 /

+0.55 (+4.54%)

BBBY Bed Bath & Beyond
$12.67 /

+0.55 (+4.54%)

BBBY Bed Bath & Beyond
$12.67 /

+0.55 (+4.54%)

Hot Stocks
Evolus expects its cash, cash equivalents sufficient for at least 12 months » 16:48
08/10/20
08/10
16:48
08/10/20
16:48
EOLS

Evolus

$3.72 /

+0.22 (+6.29%)

Evolus expects its cash,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EOLS Evolus
$3.72 /

+0.22 (+6.29%)

EOLS Evolus
$3.72 /

+0.22 (+6.29%)

07/07/20 SunTrust
Evolus price target lowered to $6 from $12 at SunTrust
07/07/20 Mizuho
Evolus downgraded to Neutral from Buy at Mizuho
07/07/20 H.C. Wainwright
Evolus price target lowered to $7 from $15 at H.C. Wainwright
06/02/20 Mizuho
Evolus fundamentals unchanged despite ITC delay, says Mizuho
EOLS Evolus
$3.72 /

+0.22 (+6.29%)

  • 07
    Nov
EOLS Evolus
$3.72 /

+0.22 (+6.29%)

EOLS Evolus
$3.72 /

+0.22 (+6.29%)

Earnings
DHT Holdings reports Q2 adjusted EPS 93c, consensus 82c » 16:48
08/10/20
08/10
16:48
08/10/20
16:48
DHT

DHT Holdings

$5.62 /

-0.1 (-1.75%)

Reports Q2 adjusted net…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DHT DHT Holdings
$5.62 /

-0.1 (-1.75%)

DHT DHT Holdings
$5.62 /

-0.1 (-1.75%)

06/18/20
Fly Intel: Top five analyst downgrades
06/18/20 Stifel
DHT Holdings downgraded to Hold from Buy at Stifel
06/02/20 Fearnley
DHT Holdings downgraded to Hold from Buy at Fearnley
05/28/20 DNB Markets
DHT Holdings upgraded to Buy from Hold at DNB Markets
DHT DHT Holdings
$5.62 /

-0.1 (-1.75%)

  • 19
    Nov
DHT DHT Holdings
$5.62 /

-0.1 (-1.75%)

DHT DHT Holdings
$5.62 /

-0.1 (-1.75%)

Hot Stocks
Sinclair Broadcast settles three derivative lawsuits » 16:48
08/10/20
08/10
16:48
08/10/20
16:48
SBGI

Sinclair Broadcast

$21.07 /

+0.65 (+3.18%)

Sinclair Broadcast has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SBGI Sinclair Broadcast
$21.07 /

+0.65 (+3.18%)

SBGI Sinclair Broadcast
$21.07 /

+0.65 (+3.18%)

07/20/20 Wolfe Research
Sinclair Broadcast downgraded to Peer Perform from Outperform at Wolfe Research
06/24/20 Benchmark
Sinclair Broadcast the 'obvious winner' in baseball's return, says Benchmark
05/05/20 B. Riley FBR
Sinclair Broadcast price target lowered to $17 from $22 at B. Riley FBR
05/04/20 Wells Fargo
Sinclair Broadcast downgraded to Underweight from Equal Weight at Wells Fargo
SBGI Sinclair Broadcast
$21.07 /

+0.65 (+3.18%)

SBGI Sinclair Broadcast
$21.07 /

+0.65 (+3.18%)

SBGI Sinclair Broadcast
$21.07 /

+0.65 (+3.18%)

Earnings
NGL Energy Partners reports Q1 EPS (44c), consensus (11c) » 16:46
08/10/20
08/10
16:46
08/10/20
16:46
NGL

NGL Energy Partners

$4.92 /

+0.28 (+6.03%)

Reports Q1 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NGL NGL Energy Partners
$4.92 /

+0.28 (+6.03%)

NGL NGL Energy Partners
$4.92 /

+0.28 (+6.03%)

07/22/20 Wells Fargo
NGL Energy Partners downgraded to Underweight at Wells Fargo
07/22/20 Wells Fargo
NGL Energy Partners downgraded to Underweight from Equal Weight at Wells Fargo
06/03/20 RBC Capital
NGL Energy Partners price target raised to $7 from $5 at RBC Capital
04/02/20 Credit Suisse
NGL Energy Partners downgraded to Underperform from Neutral at Credit Suisse
NGL NGL Energy Partners
$4.92 /

+0.28 (+6.03%)

NGL NGL Energy Partners
$4.92 /

+0.28 (+6.03%)

Earnings
Evolus reports Q2 EPS (63c), consensus (70c) » 16:45
08/10/20
08/10
16:45
08/10/20
16:45
EOLS

Evolus

$3.72 /

+0.22 (+6.29%)

Reports Q2 revenue $7.8M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EOLS Evolus
$3.72 /

+0.22 (+6.29%)

EOLS Evolus
$3.72 /

+0.22 (+6.29%)

07/07/20 SunTrust
Evolus price target lowered to $6 from $12 at SunTrust
07/07/20 Mizuho
Evolus downgraded to Neutral from Buy at Mizuho
07/07/20 H.C. Wainwright
Evolus price target lowered to $7 from $15 at H.C. Wainwright
06/02/20 Mizuho
Evolus fundamentals unchanged despite ITC delay, says Mizuho
EOLS Evolus
$3.72 /

+0.22 (+6.29%)

  • 07
    Nov
EOLS Evolus
$3.72 /

+0.22 (+6.29%)

EOLS Evolus
$3.72 /

+0.22 (+6.29%)

Syndicate
Calithera Biosciences files $250M mixed securities shelf  16:45
08/10/20
08/10
16:45
08/10/20
16:45
CALA

Calithera Biosciences

$4.71 /

+0.21 (+4.67%)

 
ShowHide Related Items >><<
CALA Calithera Biosciences
$4.71 /

+0.21 (+4.67%)

CALA Calithera Biosciences
$4.71 /

+0.21 (+4.67%)

05/11/20 Citi
Calithera Biosciences price target raised to $10 from $7 at Citi
05/08/20 H.C. Wainwright
Calithera Biosciences price target raised to $9.50 from $7 at H.C. Wainwright
03/27/20
Fly Intel: Top five analyst initiations
03/27/20 Jefferies
Jefferies starts Calithera at Buy ahead of three data catalysts
CALA Calithera Biosciences
$4.71 /

+0.21 (+4.67%)

  • 16
    Apr
CALA Calithera Biosciences
$4.71 /

+0.21 (+4.67%)

Earnings
Adaptive Biotechnologies reports Q2 EPS (26c), consensus (28c) » 16:44
08/10/20
08/10
16:44
08/10/20
16:44
ADPT

Adaptive Biotechnologies

$37.62 /

-0.62 (-1.62%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ADPT Adaptive Biotechnologies
$37.62 /

-0.62 (-1.62%)

ADPT Adaptive Biotechnologies
$37.62 /

-0.62 (-1.62%)

06/18/20 Guggenheim
Adaptive to benefit from increased MRD testing by oncologists, says Guggenheim
06/03/20
Fly Intel: Top five analyst initiations
06/03/20 Goldman Sachs
Adaptive Biotechnologies initiated with a Buy at Goldman Sachs
05/19/20 Guggenheim
Adaptive Biotechnologies price target raised to $50 from $44 at Guggenheim
ADPT Adaptive Biotechnologies
$37.62 /

-0.62 (-1.62%)

  • 16
    Jul
  • 24
    Jan
ADPT Adaptive Biotechnologies
$37.62 /

-0.62 (-1.62%)

Syndicate
Floor & Decor announces offering of 5.69M shares of common stock for holders » 16:44
08/10/20
08/10
16:44
08/10/20
16:44
FND

Floor & Decor

$67.99 /

+0.18 (+0.27%)

Floor & Decor…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FND Floor & Decor
$67.99 /

+0.18 (+0.27%)

FND Floor & Decor
$67.99 /

+0.18 (+0.27%)

08/07/20 Wedbush
Flooring companies not excluded from tariffs under USTR order, says Wedbush
08/03/20 Loop Capital
Floor & Decor price target raised to $70 from $40 at Loop Capital
08/03/20 BofA
Floor & Decor upgraded to Buy from Neutral at BofA
08/03/20 BofA
Floor & Decor upgraded to Buy from Neutral at BofA
FND Floor & Decor
$67.99 /

+0.18 (+0.27%)

  • 20
    May
  • 15
    Nov
FND Floor & Decor
$67.99 /

+0.18 (+0.27%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.